Lixte Biotechnology Holdings Stock Net Asset

LIXTW Stock  USD 0.03  0.01  21.74%   
Lixte Biotechnology Holdings fundamentals help investors to digest information that contributes to Lixte Biotechnology's financial success or failures. It also enables traders to predict the movement of Lixte Stock. The fundamental analysis module provides a way to measure Lixte Biotechnology's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Lixte Biotechnology stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Lixte Biotechnology Holdings Company Net Asset Analysis

Lixte Biotechnology's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.

Net Asset

 = 

Current Market Value

-

Current Liabilities

More About Net Asset | All Equity Analysis

Current Lixte Biotechnology Net Asset

    
  4.31 M  
Most of Lixte Biotechnology's fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Lixte Biotechnology Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Lixte Net Asset Driver Correlations

Understanding the fundamental principles of building solid financial models for Lixte Biotechnology is extremely important. It helps to project a fair market value of Lixte Stock properly, considering its historical fundamentals such as Net Asset. Since Lixte Biotechnology's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Lixte Biotechnology's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Lixte Biotechnology's interrelated accounts and indicators.
0.96-0.97-0.760.241.0-0.30.460.91-0.11-0.660.350.920.950.940.01
0.96-1.0-0.840.210.96-0.40.420.88-0.14-0.710.340.920.980.98-0.27
-0.97-1.00.83-0.22-0.970.38-0.43-0.890.170.72-0.34-0.92-0.97-0.970.23
-0.76-0.840.83-0.45-0.750.38-0.51-0.720.080.71-0.69-0.87-0.81-0.820.43
0.240.21-0.22-0.450.240.130.660.250.33-0.010.480.220.160.17-0.06
1.00.96-0.97-0.750.24-0.290.460.91-0.11-0.660.340.910.950.940.01
-0.3-0.40.380.380.13-0.290.16-0.450.120.18-0.21-0.49-0.45-0.460.38
0.460.42-0.43-0.510.660.460.160.290.31-0.540.290.390.410.4-0.02
0.910.88-0.89-0.720.250.91-0.450.29-0.08-0.530.470.90.90.89-0.04
-0.11-0.140.170.080.33-0.110.120.31-0.080.17-0.06-0.08-0.08-0.080.06
-0.66-0.710.720.71-0.01-0.660.18-0.54-0.530.17-0.3-0.72-0.7-0.70.22
0.350.34-0.34-0.690.480.34-0.210.290.47-0.06-0.30.510.350.35-0.09
0.920.92-0.92-0.870.220.91-0.490.390.9-0.08-0.720.510.930.92-0.13
0.950.98-0.97-0.810.160.95-0.450.410.9-0.08-0.70.350.931.0-0.22
0.940.98-0.97-0.820.170.94-0.460.40.89-0.08-0.70.350.921.0-0.27
0.01-0.270.230.43-0.060.010.38-0.02-0.040.060.22-0.09-0.13-0.22-0.27
Click cells to compare fundamentals
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
Competition

Lixte Total Assets

Total Assets

2.19 Million

At this time, Lixte Biotechnology's Total Assets are fairly stable compared to the past year.
Based on the recorded statements, Lixte Biotechnology Holdings has a Net Asset of 4.31 M. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The net asset for all United States stocks is notably lower than that of the firm.

Lixte Net Asset Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Lixte Biotechnology's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Lixte Biotechnology could also be used in its relative valuation, which is a method of valuing Lixte Biotechnology by comparing valuation metrics of similar companies.
Lixte Biotechnology is currently under evaluation in net asset category among its peers.

Lixte Fundamentals

About Lixte Biotechnology Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Lixte Biotechnology Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Lixte Biotechnology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Lixte Biotechnology Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Lixte Stock Analysis

When running Lixte Biotechnology's price analysis, check to measure Lixte Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lixte Biotechnology is operating at the current time. Most of Lixte Biotechnology's value examination focuses on studying past and present price action to predict the probability of Lixte Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lixte Biotechnology's price. Additionally, you may evaluate how the addition of Lixte Biotechnology to your portfolios can decrease your overall portfolio volatility.